Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06065098 · ClinicalTrials.gov registry record · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
A NA study of Hypertension and Diabetes, sponsored by Tulane University.
- Recruiting
- Registry status
- NA
- Development phase
- 806
- Enrollment target
- 1
- Study location
NCT06065098 is a NA study of Hypertension and Diabetes that is actively recruiting participants, run by Tulane University. The registered enrollment target is 806 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06065098, a NA study of Hypertension and Diabetes, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- NA
- Development phase
- 806 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiovascular disease (CVD) is the leading cause of death in the US general population. Although CVD mortality rates declined for both Black and White populations during the past two decades, they are still higher in Black adults than White adults. There are also persistent disparities in CVD risk factors with higher prevalence of obesity, hypertension, and diabetes in Black compared to White populations. In addition, CVD and risk factors are more prevalent in the residents of Louisiana compared to the US general population. The Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health (CHERISH) study will use a church-based community health worker (CHW)-led multifaceted intervention to address racial inequities in CVD risk factors in predominantly Black communities in New Orleans, Louisiana. The primary aim of the CHERISH study is to compare the impact of two implementation strategies - a CHW-led multifaceted strategy and a group-based education strategy - for delivering interventions recommended by the 2019 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Primary Prevention of Cardiovascular Disease on implementation and clinical effectiveness outcomes in predominantly Black church community members over 18 months.
Conditions Studied
Interventions
- BEHAVIORAL Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD
Study Locations (1)
Louisiana
- Tulane University - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 806 participants |
| Start Date | 2023-09-28 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06065098
The ClinicalTrials.gov registry entry for NCT06065098 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 806 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (77% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD is the first listed.
NCT06065098 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT06065098 about?
NCT06065098 is a clinical study titled "Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health". Cardiovascular disease (CVD) is the leading cause of death in the US general population. Although CVD mortality rates declined for both Black and White populations during the past two decades, they are still higher in Black adults than White adults. There are also persistent disparities in CVD risk ...
What is the current status of trial NCT06065098?
This trial is currently recruiting. It is a NA study. The enrollment target is 806 participants. The study started on 2023-09-28. Estimated completion is 2027-08-31.
What conditions does trial NCT06065098 study?
This clinical trial studies the following conditions: Hypertension, Diabetes, Cardiovascular Diseases, Hypercholesterolemia.
What interventions are being tested in trial NCT06065098?
The interventions under investigation include: Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD (BEHAVIORAL).
Who is sponsoring clinical trial NCT06065098?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06065098 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.